Ivan Hyep - Net Worth and Insider Trading
Ivan Hyep Net Worth
The estimated net worth of Ivan Hyep is at least $3 Million dollars as of 2026-09-10. Ivan Hyep is the CFO of Bicara Therapeutics Inc and owns about 129,855 shares of Bicara Therapeutics Inc (BCAX) stock worth over $3 Million. Details can be seen in Ivan Hyep's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ivan Hyep has not made any transactions after 2026-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ivan Hyep
Ivan Hyep Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ivan Hyep owns 1 companies in total, including Bicara Therapeutics Inc (BCAX) .
Click here to see the complete history of Ivan Hyep’s form 4 insider trades.
Insider Ownership Summary of Ivan Hyep
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| BCAX | Bicara Therapeutics Inc | 2026-08-10 | Chief Financial Officer |
Ivan Hyep Latest Holdings Summary
Ivan Hyep currently owns a total of 1 stock. Ivan Hyep owns 129,855 shares of Bicara Therapeutics Inc (BCAX) as of August 10, 2026, with a value of $3 Million.
Latest Holdings of Ivan Hyep
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc | 2026-08-10 | 129,855 | 23.64 | 3,069,772 |
Holding Weightings of Ivan Hyep
Ivan Hyep Form 4 Trading Tracker
According to the SEC Form 4 filings, Ivan Hyep has made a total of 11 transactions in Bicara Therapeutics Inc (BCAX) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Bicara Therapeutics Inc is the sale of 12,500 shares on August 10, 2026, which brought Ivan Hyep around $349,625.
Insider Trading History of Ivan Hyep
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Ivan Hyep Trading Performance
Ivan Hyep Ownership Network
Ownership Network List of Ivan Hyep
Ownership Network Relation of Ivan Hyep
Ivan Hyep Owned Company Details
What does Bicara Therapeutics Inc do?
Who are the key executives at Bicara Therapeutics Inc?
Ivan Hyep is the Chief Financial Officer of Bicara Therapeutics Inc. Other key executives at Bicara Therapeutics Inc include Chief Financial Officer Jennifer Larson , President and COO Ryan Cohlhepp , and director & Chief Executive Officer Claire Mazumdar .
Bicara Therapeutics Inc (BCAX) Insider Trades Summary
Over the past 18 months, Ivan Hyep made 11 insider transaction in Bicara Therapeutics Inc (BCAX) with a net sale of 150,900. Other recent insider transactions involving Bicara Therapeutics Inc (BCAX) include a net sale of 198,000 shares made by Ryan Cohlhepp , a net sale of 200,000 shares made by Claire Mazumdar , and a net sale of 60,500 shares made by David Raben .
In summary, during the past 3 months, insiders sold 108,000 shares of Bicara Therapeutics Inc (BCAX) in total and bought 0 shares, with a net sale of 108,000 shares. During the past 18 months, 754,011 shares of Bicara Therapeutics Inc (BCAX) were sold and 300,000 shares were bought by its insiders, resulting in a net sale of 454,011 shares.
Bicara Therapeutics Inc (BCAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bicara Therapeutics Inc Insider Transactions
Ivan Hyep Mailing Address
Above is the net worth, insider trading, and ownership report for Ivan Hyep. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ivan Hyep's mailing address is: Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
